FOSUN HEALTH Logo

Lymphoma Causes

catalogue

Lymphoma Causes

Lymphoma Causes

Lymphoma is the cancer of a cell whose job is to divide rapidly in response to a threat — and then to stop. Almost everything that is genuinely linked to it works through that mechanism: it either provokes chronic immune stimulation that keeps lymphocytes dividing, or it impairs the immune control that would normally remove the cells that divide wrongly. Understanding the mechanism is what separates the risk factors that matter from the ones that circulate online but have little behind them.

Immune suppression and chronic immune stimulation

The thread that runs through the strongest risk factors is that lymphocytes divide, and the immune system normally stops them dividing wrongly. Either side of that balance can be disturbed:

  • HIV infection — the risk of lymphoma in people living with HIV is substantially higher than in the general population, and it is one of the acquired immunodeficiency states most clearly linked to specific subtypes including aggressive B-cell and Burkitt lymphoma.
  • Organ transplantation — the drugs used to prevent rejection suppress the immune response that would otherwise control abnormal lymphocytes. The risk relates to the intensity and duration of immunosuppression, which is why the dose is reduced where possible over the years after transplant.
  • Immunosuppressive treatment for other conditions — including methotrexate and biological drugs used in rheumatoid arthritis and other inflammatory diseases; some lymphomas arising in that setting regress when the drug is withdrawn.
  • Chronic immune stimulation — the persistent lymphocyte activation caused by an ongoing infection, an autoimmune disease or a chronic inflammatory disorder, which provides the repeated cell divisions in which damaging changes can accumulate.
  • Increasing age — the immune system becomes less effective and less tightly regulated with age, which is one reason most lymphomas are diagnosed in older adults.

One practical conclusion follows easily. For people living with HIV, effective antiretroviral treatment that restores immune function substantially reduces the risk of lymphoma, which is one of the several reasons treatment is recommended irrespective of the cell count. For patients on long-term immunosuppressive treatment, the dose and the duration are reviewed periodically, and unexplained lymph node enlargement or a change in the blood count should not simply be attributed to the underlying disease. Understanding the mechanism is what makes those signals visible.

Infections with a specific link

A small number of infections are causally linked to lymphoma, in each case through a defined mechanism rather than as a general suspicion. These are the ones the evidence supports:

  • Epstein-Barr virus — infects almost everyone and usually causes nothing lasting, but it is found in the tumour cells of several lymphomas, including Hodgkin lymphoma, Burkitt lymphoma and extranodal NK/T-cell lymphoma of nasal type, which is more frequent in East Asia.
  • Helicobacter pylori — chronic infection of the stomach lining is linked to gastric MALT lymphoma, and eradicating it leads to regression of the lymphoma in a substantial proportion of patients with early disease.
  • Hepatitis C virus — associated with marginal zone and some other lymphomas; treating the infection has been followed by regression of the lymphoma in some patients.
  • Human T-lymphotropic virus type 1 — linked to a specific aggressive T-cell lymphoma, and found in defined geographic areas.
  • Human herpesvirus 8, associated with a rare lymphoma arising in body cavities, and Borrelia burgdorferi, linked to a form of cutaneous lymphoma in Europe.

Two conclusions follow. First, the existence of an infectious trigger does not mean lymphoma is contagious — these viruses are very common and the lymphomas associated with them are rare, which tells you that other factors take part in every case. Second, and more usefully, some of these associations can be acted on: eradicating Helicobacter pylori is part of the standard management of gastric MALT lymphoma, and treating hepatitis C is part of managing the lymphomas linked to it. If you are diagnosed with gastric MALT lymphoma, it is worth confirming that Helicobacter pylori has been tested for and dealt with.

Autoimmune and inflammatory conditions

Several autoimmune diseases are associated with an increased risk of particular lymphomas, and the reason is the same chronic stimulation described above. The associations that are well established are these:

  • Sjogren's syndrome — linked to marginal zone lymphoma of the salivary glands and to a higher risk of an aggressive lymphoma over time.
  • Hashimoto's thyroiditis — associated with lymphoma of the thyroid, which typically presents as a gland that enlarges rapidly after years of stable thyroid disease.
  • Coeliac disease — linked to a specific T-cell lymphoma of the small bowel, particularly in patients whose disease has not responded to a gluten-free diet.
  • Rheumatoid arthritis and systemic lupus erythematosus — associated with an increased risk, part of which relates to the disease activity itself and part to the immunosuppressive drugs used to treat it.
  • Chronic inflammatory conditions generally — including long-standing inflammatory bowel disease and chronic skin inflammation, where persistent lymphoid stimulation occurs.

Keeping a sense of proportion matters: these conditions are common, the lymphomas associated with them are not, and the great majority of people diagnosed with them will never develop lymphoma. What the association really supports is not anxiety but a slightly lower threshold for investigating a change — a salivary gland or a thyroid that enlarges quickly, a newly persistent enlarged node, or new symptoms in an autoimmune disease that has been stable for years. Those are the moments worth arranging an investigation for, rather than waiting for the next routine appointment.

Occupational and treatment exposures

A smaller but real group of risk factors concerns what the body has been exposed to. These are the ones supported by evidence:

  • Agricultural pesticides and herbicides — the most consistent occupational association, found repeatedly in studies of farming populations, although the absolute increase in risk for any individual is small.
  • Organic solvents, including benzene — linked to lymphoma and to leukaemia in occupational settings, which is why exposure limits exist for them.
  • Previous radiotherapy — an increased risk of lymphoma in the treated area, appearing years later.
  • Previous chemotherapy — particularly regimens containing alkylating agents or topoisomerase inhibitors, with the risk relating to the cumulative dose and to how long ago treatment was given.
  • Hair dyes and other cosmetic exposures — studied extensively, with the evidence for a meaningful risk in modern products being weak; this is a frequently cited concern that the data do not strongly support.

Because the latency is measured in years or even decades, an exposure long ago can still be relevant — and an occupational history is exactly the information only the patient can supply. Mentioning at the first appointment that you have worked with pesticides, solvents or industrial chemicals costs nothing and may add important context, particularly in agricultural or industrial regions where such exposures are common but rarely volunteered. What should not happen is retrospective anxiety about a single contact: risks of this kind operate at the level of populations, and the increase in risk for one person from one exposure is very small.

Family history and inherited risk

Lymphoma is not, in the ordinary sense, an inherited disease, and this is one of the areas where the public impression is further from the evidence than in almost any other cancer:

  • A modest increase in risk for a first-degree relative of a patient, on the order of a small multiple rather than the substantial risks seen in some other cancers. The great majority of relatives will never develop it.
  • Occasional families with several cases, which are investigated but which account for only a small proportion of all lymphomas.
  • Inherited immune deficiency syndromes — such as common variable immunodeficiency and ataxia telangiectasia — which carry a genuinely increased risk and where surveillance is part of care.
  • Inherited variants in specific genes, identified in research studies in subsets of patients, but not yet used to recommend testing or surveillance in ordinary families.

The practical position is therefore that lymphoma is not screened for because of a family history, and no blood test or gene panel is recommended for the untested relatives of a patient. What a family history genuinely supports is vigilance rather than testing: if a close relative has had lymphoma, a node that does not settle should be investigated on the same schedule as for anyone else, and the family history should be mentioned at that appointment. Where several people across generations in one family have had lymphoma or leukaemia, or where an immune deficiency is known, it is worth discussing with a specialist whether any assessment is needed.

Who is at higher risk — and who is not

Putting the factors together, certain groups carry a higher risk than the general population:

  • People living with HIV, particularly those not on effective treatment, and people who have received an organ transplant.
  • People on long-term immunosuppressive treatment for autoimmune or inflammatory disease, especially at higher doses and over many years.
  • People with Sjogren's syndrome, coeliac disease or Hashimoto's thyroiditis, and those with another long-standing autoimmune or inflammatory condition.
  • People with a previous cancer treated with radiotherapy or with certain chemotherapy drugs, years after that treatment.
  • People with sustained occupational exposure to pesticides, organic solvents or benzene, and those in older age groups generally.

Two honest qualifications belong here. Being in one of these groups does not mean a person will develop lymphoma — most people in every one of these categories never do, and the increases are relative rather than absolute. And not being in any of them removes only a little of the risk, because the majority of patients with lymphoma have no identifiable risk factor at all. That is why a persistent enlarged node or a set of unexplained B symptoms is assessed on its own merits rather than according to a risk score — and why this page should be read as an explanation of mechanism rather than as a list of things to have been worried about. For anyone in the groups above, the useful behaviour is prompt assessment of a new symptom rather than surveillance of any kind, and the reasoning is set out on the prevention page.

Frequently Asked Questions

Did I do something that caused this?

In the great majority of cases, no — there is no identifiable cause, which is true of most people with lymphoma and is worth stating plainly. The recognised risk factors are either medical conditions a person did not choose, such as HIV infection or an autoimmune disease, or long-term occupational exposures. Even where one of those is present, it raises the statistical risk across a group rather than explaining an individual case, and many people with the same exposure never develop lymphoma. The question patients most often carry is about a missed warning sign or a period of stress, and neither of those causes lymphoma.

Is lymphoma hereditary?

It is not hereditary in the usual sense. Having a first-degree relative with lymphoma raises the risk only modestly, and the large majority of relatives never develop it. There is no genetic test or screening programme recommended for relatives of an ordinary patient, and no blood test that should be done because of a family history. Two exceptions are worth knowing: occasional families contain several cases, and inherited immune deficiency syndromes carry a real increase in risk. If several close relatives across generations have had lymphoma, leukaemia or a related cancer, that is worth raising with a specialist.

Can an infection give me lymphoma?

Certain infections are linked to particular lymphomas, but the link is not contagious in any ordinary sense. Epstein-Barr virus infects the great majority of adults worldwide and almost never leads to lymphoma; Helicobacter pylori is common and only rarely leads to gastric MALT lymphoma. Where an infectious link exists, it is one factor among several. What is useful is that some of these links can be acted upon: eradicating H. pylori is part of treating gastric MALT lymphoma, and treating hepatitis C is part of managing the lymphomas associated with it.

Can I prevent lymphoma?

There is no way to prevent it reliably, and no screening test that would detect it early. The measures that genuinely reduce risk are specific rather than general: keeping HIV infection well controlled with treatment, reviewing the dose and duration of immunosuppressive drugs with the prescribing doctor, treating H. pylori when it is found, using protective equipment in occupations with solvent or pesticide exposure, and avoiding unnecessary radiotherapy where an alternative exists. None of these is a guarantee, and none of them explains most cases. What is within a patient's control is the response to a new symptom — a node that does not settle is examined rather than waited out.

Patient Stories

Stories from our lymphoma programme, pulled automatically from the patient story library by disease tag.

View all patient stories →

Ask whether any risk factor applies in your case

Send the diagnosis, the subtype, the treatment history and any relevant past medical history. Our haematology team will return a written assessment within 48 hours of the file being complete, including whether any of the recognised associations is relevant to your case and whether any additional assessment is warranted.

Want to see the whole process first? Your full medical journey, step by step →

Book an Appointment Request a Video Consultation

Follow Fosun Health

Apply for an Appointment

Do you have test results*